287 results on '"Mercimek-Andrews, Saadet"'
Search Results
2. Review of clinical trials and guidelines for children and youth with mucopolysaccharidosis: outcome selection and measurement
3. Dodecyl creatine ester therapy: from promise to reality
4. A position statement on the post gene-therapy rehabilitation of aromatic I-amino acid decarboxylase deficiency patients
5. Assessing the quality and value of metabolic chart data for capturing core outcomes for pediatric medium-chain acyl-CoA dehydrogenase (MCAD) deficiency
6. Coagulation abnormalities and vascular complications are common in PGM1-CDG
7. Frontiers in congenital disorders of glycosylation consortium, a cross-sectional study report at year 5 of 280 individuals in the natural history cohort
8. Etiological involvement of KCND1 variants in an X-linked neurodevelopmental disorder with variable expressivity
9. Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey
10. ClinGen variant curation expert panel recommendations for classification of variants in GAMT, GATM and SLC6A8 for cerebral creatine deficiency syndromes
11. Clinical and biochemical phenotypes, genotypes, and long-term outcomes of individuals with galactosemia type I from a single metabolic genetics center in Alberta
12. Evaluation of the diagnostic accuracy of exome sequencing and its impact on diagnostic thinking for patients with rare disease in a publicly funded health care system: A prospective cohort study
13. Person Ability Scores as an Alternative to Norm-Referenced Scores as Outcome Measures in Studies of Neurodevelopmental Disorders.
14. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling.
15. Disorders of Creatine Metabolism Creatine Metabolism Disorders of Creatine Metabolism
16. Pyridoxine-Dependent Epilepsy
17. Disruptive mutations in TANC2 define a neurodevelopmental syndrome associated with psychiatric disorders.
18. Outcomes of mitochondrial long chain fatty acid oxidation and carnitine defects from a single center metabolic genetics clinic
19. Reduced guanidinoacetate in plasma of patients with autosomal dominant Fanconi syndrome due to heterozygous P341L GATM variant and study of organoids towards treatment.
20. De Novo and Inherited Loss-of-Function Variants in TLK2: Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder
21. Clinical Characteristics of Creatine Transporter Deficiency (CTD): Final Results of the Vigilan Observational Study (P8-8.002)
22. Importance of the biochemical investigations for the functional characterization of a NPC1 variant identified by exome sequencing
23. The continuously evolving phenotype of succinic semialdehyde dehydrogenase deficiency
24. Treatable Metabolic Epilepsies
25. Inherited Neurotransmitter Disorders
26. PIGG variant pathogenicity assessment reveals characteristic features within 19 families
27. Disruption of NEUROD2 causes a neurodevelopmental syndrome with autistic features via cell-autonomous defects in forebrain glutamatergic neurons
28. Functional divergence of the two Elongator subcomplexes during neurodevelopment
29. Dissecting CASK: Novel splice site variant associated with male MICPCH phenotype.
30. Etiological involvement of KCND1 variants in an X-linked neurodevelopmental disorder with variable expressivity
31. Brainstem Chipmunk Sign: A Diagnostic Imaging Clue across All Subtypes of Alexander Disease.
32. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling
33. Evaluation of the diagnostic accuracy of exome sequencing and its impact on diagnostic thinking for patients with rare disease in a publicly funded health care system: A prospective cohort study
34. Next generation of free? Points to consider when navigating sponsored genetic testing.
35. DNAJC12-associated developmental delay, movement disorder, and mild hyperphenylalaninemia identified by whole-exome sequencing re-analysis
36. Urine creatine metabolite panel as a screening test in neurodevelopmental disorders
37. Correction: Disruption of NEUROD2 causes a neurodevelopmental syndrome with autistic features via cell-autonomous defects in forebrain glutamatergic neurons
38. P002: Investigating the impact of the 2022 ClinGen missense variant interpretation recommendations for cerebral creatine deficiency syndromes*
39. Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy
40. Treatment outcome of creatine transporter deficiency: international retrospective cohort study
41. Periodic reanalysis of whole-genome sequencing data enhances the diagnostic advantage over standard clinical genetic testing
42. Prospective cohort study for identification of underlying genetic causes in neonatal encephalopathy using whole-exome sequencing
43. Genetic landscape of pediatric movement disorders and management implications
44. O04: Developing a framework for sequence variant interpretation for multiple X-linked inborn errors of metabolism: The ClinGen IEM Working Group Experience
45. Novel insights into the phenotype and long-term D-gal treatment in PGM1-CDG: a case series
46. sj-docx-1-trd-10.1177_26330040221150269 – Supplemental material for Novel insights into the phenotype and long-term D-gal treatment in PGM1-CDG: a case series
47. NKX6-2 Disease in Two Unrelated Patients with Early-Onset Spastic Quadriplegia and Diffuse Hypomyelinating Leukodystrophy
48. Diagnostic yield of clinical exome sequencing in adulthood in medical genetics clinics
49. Prospective Cohort Study for Identification of Underlying Genetic Causes in Neonatal Encephalopathy Using Whole-Exome Sequencing
50. Infantile-onset hand dystonia with intellectual disability: Clues to ARX mutations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.